At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United States based CFO’ operating in the Medical space. If you think a CFO’ is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Robert McLaughlin
CFO of Airgas
Robert McLaughlin is the Senior Vice President and Chief Financial Officer of Airgas, Inc., the nation’s leading single-source supplier of gases, welding and safety products. Robert has served in that position since 2006 after serving as Airgas’s Vice President and Controller since joining Airgas in 2001. Previously, he was Vice President-Finance for Asbury Automotive Group, a multi-billion dollar automotive retailer, after serving as Vice President of Finance and in other financial management roles with Unisource Worldwide, Inc., a multi-billion dollar international paper and industrial supply distribution company. Robert serves on the Board of Directors of publicly-traded Axalta Coating Systems, Ltd., a global leader in the development, manufacture and sale of liquid and powder coatings. He is Chairman of Axalta’s Audit Committee. Robert began his career with Ernst & Young in 1979. Robert earned his bachelor’s degree in accounting from the University of Dayton.
Follow Robert McLaughlin:
About Airgas: Airgas, an Air Liquide company, is a leading U.S. single-source supplier of gases, welding equipment and supplies, and safety products.
_______
Denise Castillo Rhodes
Executive Vice-President & Chief Financial Officer of Texas Medical Center
Denise Castillo-Rhodes is executive vice president and chief financial officer of Texas Medical Center, where she oversees accounting, finance, billing and collections, and tax compliance. Outside of her work at Texas Medical Center, Castillo-Rhodes serves on several advisory boards, including Post Oak Montessori School, The Audit and Finance Committee of Medical Bridges, Houston Livestock Show and Rodeo Ticket Services, Greater Houston Partnership’s Executive Women’s Partnership, and Greater Houston Women’s Chamber of Commerce. Castillo-Rhodes holds a Bachelor of Business Administration from the University of Texas at El Paso and a Master of Business Administration from the University of St. Thomas. She is a certified public accountant and is a member of the Texas Society of Certified Public Accountants and American Institute of Certified Public Accountants.
Follow Denise Castillo Rhodes:
About Texas Medical Center: Texas Medical Center (TMC) is a life sciences medical complex focused on patient care, research, education, and prevention.
Thomas Antonio
Vice President of Financial & CFO of Drive Medical
Thomas Antonio joined the Company in February 2004, and is primarily responsible for financial reporting. From 1986 through 1997, Thomas Antonio served as the Assistant Vice President and Controller of Charan Industries, a privately-held company which owned and operated bowling centers throughout the United States. From 1997 through February 2004, Thomas served as the Chief Financial Officer of several privately-held companies located in the metropolitan New York area.
Follow Thomas Antonio:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Cory Roberts
Chief Financial Officer of UnitedHealth Group
Cory serves as a Chief Financial Officer and Group President. Prior to SCA, Cory led the development of an analytical systems platform for a private equity portfolio company and worked in the M&A division of a southeastern investment banking group. Cory earned a Bachelor of Science from The University of Alabama.
Follow Cory Roberts:
About Triple Aim Partners, UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Lee Kalowski
Chief Financial Officer of Bicycle Therapeutics
Lee has served as chief financial officer at Tokai since September 2014. Prior to joining Tokai, he served as a vice president in global biotechnology equity research at Credit Suisse. In this role, Lee served as a senior research analyst covering the biotechnology industry, including numerous companies globally in the prostate cancer therapeutic area. Prior to Credit Suisse, Lee worked at Johnson & Johnson in mergers & acquisitions in the pharmaceutical group, where he was involved in the analysis and execution of several completed transactions, and in global pharmaceutical equity research at Sanford C. Bernstein and Prudential Equity Group. Lee holds a B.A., Phi Beta Kappa, in biology and economics, from Union College and an M.B.A. in finance and health care management from the Wharton School, University of Pennsylvania.
Follow Lee Kalowski:
About Bicycle Therapeutics: Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.
Sailesh R. Saxena
CFO of ReliantHeart
Mr. Saxena is the Chief Financial Officer and Co-Founder of ReliantHeart. He played a critical role in the acquisition of the HeartAssist5 technology. He has more than twenty-five years of leadership and consulting experience in financial services, supply chain management, information technology, research and development, and operations. He has worked with numerous private equity fund companies providing financial consulting and analysis on transactions to raise capital for acquisition or investment projects. He has an MBA from SMU Cox School of Business and Electrical engineering degree from Birla Institute of Technology and Science, Pilani (BITS), India.
Follow Sailesh R. Saxena:
About ReliantHeart: ReliantHeart, Inc. is a leading innovator in mechanical circulatory support therapies for advanced stage heart failure.
Joe Selsavage
CFO of Lemonaid Health
Follow Joe Selsavage:
About Lemonaid Health, Metromile: Lemonaid Health is a telemedicine platform that uses technology to change the way people interact with health care.
Gene Castagnini
COO, CFO, CAO & Co-founder of Biocare Medical
Gene J. Castagnini, MS, MBA, co-founded Biocare Medical LLC in 1997 and serves as its Co-Owner and Chief Financial Officer. Gene Castagnini serves as the Chief Operating Officer and Executive Vice President of Biocare Medical, LLC Gene Castagnini served as the Chief Administrative Officer and Chief Financial Officer of BioGenex Laboratories. Inc., for 10 years. Gene Castagnini’s experience includes 15 years as a Director and Officer of Medi-Physics Inc., formerly a Hoffmann-La Roche Inc. subsidiary. Gene Castagnini has a BS in accounting and an MBA in Human Resource Management from the California State University school systems.
Follow Gene Castagnini:
About Biocare Medical: Biocare Medical is a provider of immunohistochemistry instrumentation.
Alan Nielsen
Chief Financial Officer of Walgreens
Alan Nielsen is chief financial officer for Walgreen Co. based in Deerfield, Illinois. Nielsen has been with Walgreens since 1987. Prior to being promoted to his current role, Nielsen was group vice president of International Finance. Before that, he served as director of results and director of decision support systems. Previously, he held several finance and accounting roles in the company. Nielsen received a bachelor of science degree in accounting from Eastern Illinois University in 1987 and earned a CPA designation in 1990.
Follow Alan Nielsen:
About Walgreens: Walgreens provides multi-channel access to consumer goods and cost-effective pharmacy, health, and wellness services.
Leonard Bruce Jolliff
Chief Financial Officer of Vivos Inc
Leonard Bruce Jolliff, joined Advanced Medical Isotope Corporation as Chief Financial Officer in 2006. For nine years prior to joining the Company, Mr. Jolliff was a sole practitioner in the role of CFO for Hire and as a Forensic Accountant, working with companies ranging from Fortune 500 to small family operations. Mr. Jolliff is a CPA and a member of the Washington Society of CPAs. He is also a Certified Fraud Examiner and a member of the Association of Certified Fraud Examiners. Mr. Jolliff has held CFO and Controller positions in an array of industries and has worked as a CPA in public practice. Currently all of Mr. Jolliff’s energy is focused on supporting AMI’s isotope production and securing new investments which will enable the growing company to meet it’s goals.
Follow Leonard Bruce Jolliff:
About Vivos Inc: Vivos Inc develops manufacturing equipments for the production of medical isotopes used in diagnosis and treatment of diseases.
Jeanne Henry
CFO of Excel Venture Management
Jeanne joined the Excel team in 2009 and brings more than 18 years of venture capital financial management and reporting experience to the team. Previously, Jeanne was CFO and most recently COO with Atlas Venture, an international venture firm. Earlier she was an Audit Manager with Coopers & Lybrand (now PricewaterhouseCoopers). Jeanne holds a B.A. from the University of New Hampshire, an MBA from the University of Illinois, Chicago and is a Certified Public Accountant. She is a member of the AICPA, the M.A. Society of CPA’s, and a former Board member of the Private Equity CFO Association.
Follow Jeanne Henry:
About Excel Venture Management: Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond.
Neil Edwards
Chief Financial Officer of Vesselon
Neil Edwards is the CEO of Cellufun. Edwards served as the founding CEO of dotMobi, a mobile web services company, where he grew the company from a start-up to a multi-million dollar organization. At dotMobi he built a global customer base with multiple channel platforms and content partners that generated significant recurring revenue streams. Additionally,Mr. Edwards was instrumental in building a consortium of leading mobile brands including Nokia, Vodafone, Google, Telefonica, Telecom Italia, T-Mobile, Orascom, Microsoft, Visa and many others. Prior to dotMobi, he was instrumental in the growth of VeriSign and infoUSA,having served in senior leadership positions within both organizations.
Follow Neil Edwards:
About Forbes, Vesselon: Vesselon is a medical device company developing novel therapeutic Immuno-Oncology complexes.
Brian Kinard
CFO and Legal Counsel of Mojo Vision
Follow Brian Kinard:
About Mojo Vision: Mojo Vision is developing Mojo Lens, the world’s first AR smart contact lens with a built-in display that delivers Invisible Computing
Kevin Gillis
CFO / Partner of Third Rock Ventures
Kevin Gillis joined Third Rock Ventures in 2008 and oversees the operational, financial and administrative aspects of the firm. He also directs and oversees the initial operational activities for our portfolio companies. Kevin has approximately 20 years of financial experience, successfully designing, overseeing and managing the financial operations for both newly emerging and established biotech companies. Prior to joining Third Rock Ventures, Kevin was Vice President of Finance at Coley Pharmaceutical Group, supporting the company’s successful initial public offering in 2005 and overseeing the finances related to the company’s acquisition by Pfizer in 2008. Prior to Coley, Kevin served in a number of senior finance roles at Millennium Pharmaceuticals and The Coca-Cola Company. Kevin holds an MBA from Bentley University and a BA from Brandeis University.
Follow Kevin Gillis:
About Third Rock Ventures: Third Rock Ventures invests in transformational life science companies that show high growth potential
David Ben Naim
Chief Financial Officer of Microbot Medical
Follow David Ben Naim:
About Microbot Medical: Microbot Medical is the first medical device company specialized in the researching, designing, developing and commercializing.
Thomas Altier
CFO of Phreesia
Tom brings over 30 years of financial management experience to the chief financial officer role, including a “Big Four” career foundation and experience with several venture-backed, emerging-growth and SaaS businesses. As CFO of Phreesia, Tom is responsible for budgeting, forecasting, monthly reporting, financial analysis and internal controls. Prior to joining Phreesia, Tom was CFO at Perceptive Pixel, a developer of high-end, multi-touch display screens and related software, which was acquired by Microsoft in 2012. Tom is a CPA, and holds a BA and MBA from Columbia University.
Follow Thomas Altier:
About Phreesia: Phreesia automates the patient check-in process by collecting personal health information on the PhreesiaPad.
Robert Bermon
Chief Financial Officer of Invo HealthCare Holdings
Robert Bermon, CPA brings more than 20 years of senior financial management experience to the Invo Family of Companies and currently serves as the organizations chief Financial Officer. As CFO, Bob oversees the shared services support team which includes accounting, finance and human resources. Prior to Bob joining the team in 2016, he was the Executive Vice President and Chief Financial Officer at Solomon Edwards. Through streamlined business operations, financial controls and processes that drove growth, efficiency and bottom-line profit, Bob was instrumental in building the infrastructure that promoted the company’s growth. Bob’s career started with accounting firm Grant Thornton. Bob holds a Bachelor of Arts in Accounting from Temple University and is a Certified Pubic Account (CPA).
Follow Robert Bermon:
About Invo HealthCare Holdings: Founded in 1993 by Patrick McClain, an Occupational Therapist, and Mary McClain, an Educator.
Terry Colip
Founder, Managing Member & CFO of Cell Point
Terry Colip, the Founder of Cell>Point, was a founding member of the firm and has provided his expertise from its inception. Mr. Colip has 26 years of expertise in investment banking and venture capital in the healthcare industry. Prior to founding Cell>Point, Mr. Colip worked as a healthcare consultant for Coopers & Lybrand in New York. He provided equity and investment banking services for roughly $2 billion in healthcare transactions at Underwood Neuhaus & Co., Boettcher & Co., and American Health Capital, Inc. Mr. Colip was also a founding partner in Chewton Glen Energy L.L.C. This company built two electric power plants in Illinois. Many media outlets, including Fox Business Network, Fox News, NBC News Denver, ABC News Denver, CBS News Denver, and National Public Radio, have highlighted Mr. Colip. Mr. Colip earned a B.S.I.E. in 1979 from the University of Wisconsin’s College of Engineering and an M.P.A. in finance and healthcare administration from New York University in 1981. Mr. Colip donates his time and resources to charities and organizations that focus on healthcare and disability outreach.
Follow Terry Colip:
About Cell Point: Cell Point is a biotechnology company developing universal molecular imaging agents and intra-nuclear metallic therapeutics.
Brian Yoor
Senior Vice President Finance & Chief Financial Officer of Abbott
Brian Yoor is Senior Vice President Finance and Chief Financial Officer. He was appointed to his current position in June 2015. He previously served as Vice President, Investor Relations. Brian joined Abbott in August 1997, and held various financial management positions of increasing responsibility, including Controller positions in the pharmaceutical, nutrition, and diagnostic businesses, before being asked to lead Abbott’s Investor Relations effort in January 2013. Prior to joining Abbott, Brian was a certified public accountant with Arthur Andersen and held financial positions in the consumer industry with the Scotts Company and Newell Rubbermaid. “In Abbott Finance, we are the stewards that enable financial reliability and growth for Abbott, “ Says Brian. “ A strong, growing company is better able to help people around the world live their healthiest lives.” Brian serves on the board of the Clara Abbott Foundation. He is a member of NIRI, the National Investor Relations Institute. He earned his bachelor’s degree in accounting at the University of Toledo in Ohio.
Follow Brian Yoor:
About Abbott: Abbott is engaged in pharmaceuticals and manufacturing healthcare products.
Steven Schwen
Chief Financial Officer of Vensana Capital
Steve Schwen joined Split Rock Partners at the firm’s inception as Chief Financial Officer. He currently oversees the finance, accounting, operations and human resources activities of the firm. Prior to joining Split Rock Partners, Steve was Chief Financial Officer of St. Paul Venture Capital, which he joined in 1998. Before joining St. Paul Venture Capital, he spent four years in the audit practice of KPMG LLP. He provided audit and consulting services to both public and private financial services companies including investment companies, mutual funds, investment managers and investment banks. Steve became a licensed CPA in the state of Minnesota after earning a BA degree in business administration-accounting at the University of St. Thomas. He is a member of the American Institute of Certified Public Accountants and the Minnesota Society of Certified Public Accountants.
Follow Steven Schwen:
About Split Rock Partners, St. Paul Venture Capital, Vensana Capital: Vensana Capital is a venture capital investment firm that focuses on healthcare with breakthrough innovations in medical technology.
Thomas A. Lettero
CFO of Exact Imaging
CEO at NexGen Technology.
Follow Thomas A. Lettero:
About Exact Imaging, NexGen Technology: Exact Imaging is the developer of the ExactVu™ system, the first micro-ultrasound operating at 29 MHz that provides unmatched resolution.
Howard Horn
CFO of Vir Biotechnology
Howard Horn is the Chief Financial Officer of VIR. Previously, he led the Financial Planning and Corporate Finance functions at Biogen. Prior to joining Biogen, he held positions of increasing responsibility and was focused on the life sciences as a consultant with McKinsey & Company and as an equity research analyst at UBS. Howard holds an M.B.A from the Wharton School of the University of Pennsylvania and a B.A in Economics from Princeton University.
Follow Howard Horn:
About Vir Biotechnology: Vir Biotechnology is a clinical-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases.
Brent Faduski
CFO of SV Health Investors
Brent Faduski joined SVLS in October 2008 as Controller and focuses on finance and accounting matters for the firm. Prior Experience: Prior to joining SVLS, Brent was the Controller at CMGI @Ventures, the venture capital affiliate of CMGI, where he was responsible for the accounting and finance aspects of the firm. Prior to joining CMGI @Ventures, Brent was a Senior Associate in the Technology Group at PricewaterhouseCoopers where his clients included early stage venture backed companies as well as venture capital funds.
Follow Brent Faduski:
About SV Health Investors: SV Health Investors is a Boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
Brent Faduski
CFO of SV Health Investors
Brent Faduski joined SVLS in October 2008 as Controller and focuses on finance and accounting matters for the firm. Prior Experience: Prior to joining SVLS, Brent was the Controller at CMGI @Ventures, the venture capital affiliate of CMGI, where he was responsible for the accounting and finance aspects of the firm. Prior to joining CMGI @Ventures, Brent was a Senior Associate in the Technology Group at PricewaterhouseCoopers where his clients included early stage venture backed companies as well as venture capital funds.
Follow Brent Faduski:
About SV Health Investors: SV Health Investors is a Boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
Terry Brady
Chief Financial Officer of Farcast
With over 20 years of experience in finance and accounting, Terry joined Farcast in 2019. As the CFO, he leads HR, Finance, IT, Legal, and Business Analytics. His past experience includes success in public accounting, turnaround management consulting, and most recently as CFO of a large manufacturing company. He holds undergraduate and graduate degrees from the University of Notre Dame as well as an MBA from the Kellogg School of Management at Northwestern University.
Follow Terry Brady:
About Farcast: Farcast develops a diagnostic platform that delivers powerful predictions for personalized cancer treatment selection and drug development.
Marc Naughton
EVP & CFO of Cerner
As executive vice president and chief financial officer, Marc has executive responsibility for Cerner’s financial operations and business model. Playing a key role in Cerner’s rapid rise, Marc ensures the company is growing profitably while maintaining the ability to invest heavily in future growth. Additionally, he carries responsibility for Cerner properties and legal functions, which are both large organizations that facilitate Cerner’s growth. Joining Cerner in 1992 as a finance executive and tax manager, Marc established the company’s internal tax function. He then assumed leadership of Cerner’s mergers, acquisitions and finance activities. He served as the director of finance for two years before being promoted to chief financial officer. Prior to Cerner, Marc had extensive experience in the financial industry, including at Klynveld Peat Marwick Goerdeler (KPMG) and various financial management roles at the Marley Company, a Kansas City, Missouri-based multinational manufacturing company. Marc is a certified public accountant and a member of the Kansas Bar Association. He is a past president of the Kansas City chapter of the Tax Executives Institute and a current member of the University of Kansas Finance Advisory Board. Marc earned a bachelor’s degree in business administration from Southern Methodist University and a juris doctorate from the University of Kansas.
Follow Marc Naughton:
About Cerner: Cerner is a supplier of healthcare information technology solutions, services, devices, and hardware.
Harrison Hellner
Chief Financial Officer of QGenda
As Chief Financial Officer, Hellner is responsible for building all financial operations and maintaining fiscal controls to support the company’s rapid expansion. Additionally, he is responsible for strategic partnerships and M&A. Prior to joining QGenda, Hellner spent the last six years at Raymond James Healthcare Investment Banking Group working with technology businesses to help them with a variety of capital raising activities, including debt and equity financings and M&A. He holds a B.S.
Follow Harrison Hellner:
About QGenda: QGenda is the leading innovator in enterprise healthcare workforce management solutions.
James Hinrichs
Executive Vice President and Chief Financial Officer of Alere
James (“Jim”) Hinrichs joined Alere in April 2015 as Executive Vice President and Chief Financial Officer, with global responsibility for Finance, Accounting, Procurement, IT and Shared Services. Prior to his appointment as CFO of Alere, Jim Hinrichs was CFO at CareFusion Corp., a global medical technology corporation, since 2010. He held this position through the completion of Becton Dickinson’s acquisition of CareFusion in March 2015. Prior to this role, Hinrichs served as SVP of Global Customer Support and, before that, Corporate Controller of CareFusion. Previously, he was Executive Vice president and Controller of Cardinal Health, CFO of Cardinal Health’s Clinical and Medical Products segment and CFO of Cardinal Health’s Healthcare Supply Chain Services segment.. He joined Cardinal Health in February 2004, following 12 years of finance and marketing roles at Merck & Co. and two years as the CFO of SangStat Medical Corporation.
Follow James Hinrichs:
About Alere: Alere provides diagnostics and health management solutions for infectious, heart and cancer-related diseases and drug addicts.
Tony Hughes
Chief Financial Officer of NaviHealth
Tony Hughes serves as naviHealth’s Chief Revenue and Strategy Officer responsible for leading new health plan and health system business opportunities. Prior to joining naviHealth, Tony specialized in managed care mergers and acquisitions. Most recently he served as Director of Corporate Development at WellCare Health Plans and prior to that as Director of Corporate Development and Investor Relations for HealthSpring, Inc.
Follow Tony Hughes:
About NaviHealth: NaviHealth partners with health plans, health systems and post-acute providers to manage the entire continuum of post-acute care.
Michael Coggin
EVP & CFO of LifePoint Health
Michael Coggin serves as Executive Vice President and Chief Financial Officer for LifePoint Health, providing the Company corporate and healthcare finance leadership. Previously, Coggin served as Senior Vice President and Chief Accounting Officer for LifePoint since December 2008. In that role Coggin, was responsible for the Company’s external financial reporting, corporate accounting and consolidation functions, tax functions and the Company’s internal control compliance requirements. Additionally, Coggin has held certain responsibilities associated with the Company’s treasury and finance functions. Prior to joining LifePoint, Coggin was Chief Financial Officer of Specialty Care Services Group. He also served in finance leadership positions for Renal Care Group, Inc. from April 2004 until its acquisition by Fresenius Medical Care AG & Co. KGaA in March 2006. He began his professional career as an auditor with KPMG Peat Marwick.
Follow Michael Coggin:
About LifePoint Health: LifePoint Health is a leading healthcare company dedicated to Making Communities Healthier.
Victor Breed
Chief Financial Officer of Genoa
Victor Breed is Genoa, a QoL Healthcare Company’s Chief Financial Officer. Breed joined Genoa in October 2006. Breed is responsible for accounting functions, treasury management, billing, purchasing, insurance/risk management and banking and investor relationships. He plays a significant role in raising equity financing and negotiating new bank financing. Previously Breed was the EVP of Finance and Operations for a medical device company, ClearMedical, Inc. As the EVP, Breed developed and implemented a new business model and managed all operational and administrative functions including production, engineering, regulatory, finance, accounting, human resources and IT. Prior to ClearMedical, Inc., Breed served as Senior Vice President for Solucient, LLC. While with Solucient, he was the General Manager of the business unit providing performance management solutions for hospitals. In addition, he identified and evaluated potential business partners and M&A candidates and negotiated business relationships, joint ventures and marketing arrangements. Before working for Solucient, LLC, Breed was the COO and CFO for HBS International. As COO/CFO Breed oversaw daily operations and developed strategies for accelerating growth by merger or acquisition. HBS International was one of the Deloitte & Touche Technology Fast 500; a list of the fastest growing technology companies in North America and on the 2000 Healthcare Informatics list of 10 Most Influential Healthcare IT Companies. Breed is a graduate of Lake Superior State University with a Bachelor of Science in Accounting. He is also a member of both the American Institute of Certified Public Accountants and the Washington Society of Certified Public Accountants.
Follow Victor Breed:
About Genoa: Genoa, a QoL Healthcare Company is the pharmacy and telepsychiatry provider serving the behavioral health and addiction treatment.
Gillian Munson
Chief Financial Officer of Iora Health
Follow Gillian Munson:
About Iora Health: Iora Health is a healthcare company that helps patients manage their health and navigate the healthcare system.
Rick Kent
CFO of Paramit Corporation
Rick Kent is the Chief Financial Officer at Paramit Corporation.
Follow Rick Kent:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
Tom LaRose
CFO of Paramit Corporation
Tom LaRose is CFO at Paramit Corporation.
Follow Tom LaRose:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
Niall O’Cathasaigh
CFO of Prealize Health
As CFO, Niall O’Cathasaigh is the senior executive responsible for sound fiscal management of all financial operations and human resource activities, as well as overseeing capital raising efforts and financial reporting for board and other stakeholder communications. Niall has been working as a founder and consultant with startups and growth stage companies in the US, Europe and Africa for over 20 years. He works with Countsy, an innovative professional services firm that specializes in working with venture funded startups to provide end to end strategic and back office services. His experience includes work with over 30 startups in the Bay Area, with a focus on healthcare companies, providing financial transparency and strategic guidance as well as enabling funding rounds and acquisitions. Niall is also a founder and partner of ManoCap, a private equity fund management company that makes equity investments in small to mid-cap enterprises in West Africa. Prior to that he worked at Apple’s European divisions in Ireland and France. Niall is a qualified financial professional (CIMA). He holds a postgraduate degree in business from University College Dublin, and a joint BA in History and Classical Civilization from University College Galway and Universite De Poitiers.
Follow Niall O’Cathasaigh:
About Prealize Health: Prealize Health uses machine learning to transform healthcare from reactive to proactive.
Karen Adams
CFO of Arrivo BioVentures LLC
Karen Adams has a 30 year career as a finance professional working with companies across a broad range of industries with the last 15 years focused on life sciences and technology. After starting her career as an Internal Auditor with International Paper Company, Inc., Karen Adams has held financial leadership positions with companies in software, professional services and biotechnology industries. Most recently, Karen Adams has been part of the management team, in the CFO role, responsible for the creation and sale of two companies (Addrenex Pharmaceuticals to Shionogi Pharma and Neuronex to Acorda Therapeutics) and Aerial BioPharma’s ADX-N05 asset sale to Jazz Pharmaceuticals. While Karen Adams life sciences experience has been primarily focused on early-stage, privately funded companies she was brought on as Assistant Controller at Millennium Pharmaceuticals, Inc. during its merger with COR Therapeutics – among the largest such mergers in the history of the biotech industry at that time. After Millennium Pharmaceuticals, Karen Adams went on to work with several early stage biotechnology ventures including Surface Logix, Inc., Compound Therapeutics, Inc., Galenea Corporation, BG Medicine, Inc., and Micell Technologies, Inc. Karen Adams contribution was concentrated on the creation of dynamic, integrated financial forecasting models as well as the implementation of core business structure. Karen Adams graduated from Boston College earning a BS in Management, majoring in Finance.
Follow Karen Adams:
About Arrivo BioVentures LLC, Emergo Therapeutics, KJA Associates, QuatroBio: Arrivo BioVentures is a pharmaceutical development company which focuses on identifying biologics and molecules to improve patient care.
Karen Adams
CFO of Arrivo BioVentures LLC
Karen Adams has a 30 year career as a finance professional working with companies across a broad range of industries with the last 15 years focused on life sciences and technology. After starting her career as an Internal Auditor with International Paper Company, Inc., Karen Adams has held financial leadership positions with companies in software, professional services and biotechnology industries. Most recently, Karen Adams has been part of the management team, in the CFO role, responsible for the creation and sale of two companies (Addrenex Pharmaceuticals to Shionogi Pharma and Neuronex to Acorda Therapeutics) and Aerial BioPharma’s ADX-N05 asset sale to Jazz Pharmaceuticals. While Karen Adams life sciences experience has been primarily focused on early-stage, privately funded companies she was brought on as Assistant Controller at Millennium Pharmaceuticals, Inc. during its merger with COR Therapeutics – among the largest such mergers in the history of the biotech industry at that time. After Millennium Pharmaceuticals, Karen Adams went on to work with several early stage biotechnology ventures including Surface Logix, Inc., Compound Therapeutics, Inc., Galenea Corporation, BG Medicine, Inc., and Micell Technologies, Inc. Karen Adams contribution was concentrated on the creation of dynamic, integrated financial forecasting models as well as the implementation of core business structure. Karen Adams graduated from Boston College earning a BS in Management, majoring in Finance.
Follow Karen Adams:
About Arrivo BioVentures LLC, Emergo Therapeutics, KJA Associates, QuatroBio: Arrivo BioVentures is a pharmaceutical development company which focuses on identifying biologics and molecules to improve patient care.
Glenn S. Boehnlein
Chief Financial Officer & Vice President of Stryker
Follow Glenn S. Boehnlein:
About Stryker: Stryker is a medical technology company that offers products and services in orthopaedics.
Isaac Ro
Chief Financial Officer of Sema4
Isaac Ro has 20 years of financial leadership and experience, with a strong focus on the medical technology and life sciences space. As Chief Financial Officer (CFO) at Sema4, Isaac is responsible for leading all aspects of financial strategy, management, and planning. Prior to joining Sema4, Isaac served as CFO of Thrive Earlier Detection Corp., a company dedicated to incorporating earlier detection of cancer into routine medical care. In this capacity, he led the sale of Thrive to Exact Sciences Corp. (Nasdaq: EXAS) for $2.15 billion after rapidly scaling the company and raising $257 million in a Series B financing. Before Thrive, Isaac led the U.S. Medical Technology team at Goldman Sachs where he covered the Life Science Tools, Diagnostics, and Medical Technology sectors. He also held a similar role at SVB Leerink. His career as an equity analyst spanned 16 years, over 60 publicly traded companies, and numerous IPOs and equity financing transactions. Isaac holds a B.A. in History and was pre-med at Middlebury College.
Follow Isaac Ro:
About Sema4: Sema4 uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.
Dan L. Dearen
President & Chief Financial Officer of Axonics Modulation Technologies
Follow Dan L. Dearen:
About Axonics Modulation Technologies: Axonics Modulation Technologies is a pre-revenue company developing novel implantable neuromodulation.
Jaime Bartushak
CFO of Citius Pharmaceuticals
Follow Jaime Bartushak:
About Citius Pharmaceuticals: Citius Pharmaceuticals is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products.
Susan M. Kanaya
Senior Vice President, Finance, Chief Financial Officer and Secretary of ChemoCentryx
Ms. Susan M. Kanaya has served as our Senior Vice President, Finance, and Chief Financial Officer since January 2006, and Secretary since February 2006. Prior to joining us, Ms. Kanaya served as Senior Vice President, Finance, and Chief Financial Officer at Kosan Biosciences Inc., a biotechnology company, from 1999 to 2005. Prior to this, she served in financial management positions at SUGEN, Inc., a biotechnology company, from 1994 to 1999, most recently as Vice President, Finance, and Treasurer. Ms. Kanaya also served as Controller with high technology companies and as a public accountant with KPMG. Ms. Kanaya received her B.S. in business administration from the University of California, Berkeley.
Follow Susan M. Kanaya:
About ChemoCentryx: ChemoCentryx develops orally administered small molecule therapeutics that target chemokine receptors and related chemo-attractants.
Brian Jung
CFO of AiCure
Brian Jung is the CFO of AiCure.
Follow Brian Jung:
About AiCure: AiCure is an advanced data analytics company that uses artificial intelligence to understand how patients respond to treatments.
Phillip Donenberg
Senior Vice President, Chief Financial Officer of AveXis
Phillip brings more than 23 years of leadership expertise in finance, mergers and acquisitions (M&A) and operations focused in the pharmaceutical and healthcare industries. His background includes recent experience with a gene therapy company, AveXis, Inc., where he served as the Chief Financial Officer and Senior Vice President until June 15, 2018, following its acquisition by Novartis. Phillip has held leadership roles overseeing strategic transactions, financing management and accounting operations, controls and reporting processes for growing life sciences companies. Most recently, he was Chief Financial Officer and Senior Vice President of Depomed, Inc. Previously, Phillip was the Chief Financial Officer at RestorGenex Corporation from 2014 to 2016, when RestorGenex merged with Diffusion Pharmaceuticals, Inc. From 1998 to 2013, he served as the Chief Financial Officer at BioSante Pharmaceuticals, Inc. until the merger of the company with ANIP Pharmaceuticals, Inc. Phillip earned a bachelor’s degree in accountancy from the University of Illinois, and he is a Certified Public Accountant.
Follow Phillip Donenberg:
About AveXis, Jaguar Gene Therapy: AveXis is a Biotech company is focused on developing gene therapy for patients with rare and life-threatening neurological genetic diseases.
Linda C. Bain
CFO of Codiak Biosciences
Linda C. Bain, CPA, has served as our vice president of finance and business operations since October 2011 and as our treasurer since March 2013. Previously, she served as vice president of corporate finance at Genzyme from September 2008 to September 2011, at Fidelity Investments from September 2007 to September 2008 and a number of positions at AstraZeneca from May 2000 to September 2007. She received her B.S. from the University of the Orange Free State in South Africa.
Follow Linda C. Bain:
About Codiak Biosciences: Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.
Mike Browder
Executive Vice President & CFO of RCCH HealthCare Partners
Mike Browder served as Executive Vice President and CFO for RegionalCare since 2011. Mike also led Essent Healthcare as CEO for four years. Mike previously served as Senior Vice President and Chief Financial Officer for TMC HealthCare, Tucson Arizona, for two years where he was responsible for the financial aspects of all TMC HealthCare companies, including the Tucson Medical Center. From 1993 to 1999, Mike served as Vice President of Operations Finance for Health Management Associates, Inc. Mike began his career in the Atlanta office of Ernst & Young where he audited and consulted with a broad array of healthcare-related companies. Mike currently serves on the Board of Directors of the Federation of American Hospitals. Mike is a member of the American Institute of Certified Public Accountants, the Tennessee Society of Certified Public Accountants, Financial Executives Institute and an advanced member of the Healthcare Financial Management Association. Mike earned a B.B.A in accounting from the University of Georgia’s J.M. Tull School of Accounting.
Follow Mike Browder:
About RCCH HealthCare Partners: RCCH HealthCare Partners provides healthcare services.
Stephen Mengert
CFO of eviCore healthcare
Stephen Mengert is the chief financial officer of [Medsolutions](https://www.crunchbase.com/organization/evicore-healthcare), a health technology company that offers proven, diversified medical benefit management solutions. He was previously the chief financial officer of Matria Healthcare. Before joining Matria Healthcare, he served as the chief financial officer of Tatum CFO Partners, Pediatric Services of America. He also served in numerous financial management positions, and currently also serves as director of Informed Medical Decisions and Adeptus Health. He is also a member of the Financial Executives Institute. Mengert holds a bachelor’s degree in finance and an MBA in finance from Georgia State University.
Follow Stephen Mengert:
About eviCore healthcare: eviCore healthcare offers a range of diversified medical benefit management solutions.
Bert Zimmerli
Senior VP, CFO of Intermountain Healthcare
Follow Bert Zimmerli:
About Intermountain Healthcare: Intermountain Healthcare is a nonprofit health system.
Ethan Einwohner
Chief Financial Officer of Specified Testing Labs
I Ethan Einwohner formed Specified Testing Labs, LLC, a roll-up of environmental testing laboratories, in August 2013. Under Specified, Ethan led the acquisitions of the testing lab assets of: International Hydronics Corporation (Oct 2013); New Jersey Analytical Labs (Nov, 2013), CNA Environmental (Dec 2013); and Smith Environmental Labs (Apr 2014). At Specified, Ethan manages all financial aspects of the firm and has responsibilities for its acquisition and integration activities. With his laboratory operations team, Ethan forms and executes company strategy .
Follow Ethan Einwohner:
About CNA Environmental, Recurrent Capital Bridge Fund, Specified Testing Labs: Specified Testing Laboratories, LLC is a holding company of testing laboratories and related operating companies. Formed in September .
Martin Jackson
Executive Vice President & Chief Financial Officer of Select Medical
Martin F. Jackson has served as Executive Vice President & Chief Financial Officer for Select Medical since May 1999. Mr. Jackson previously served as a Managing Director of the Health Care Investment Banking Group for CIBC Oppenheimer from January 1997 to May 1999. Prior to that time, he served as Senior Vice President, Health Care Finance with McDonald & Company Securities, Inc. from January 1994 to January 1997. Prior to 1994, Mr. Jackson held senior financial positions with Van Kampen Merritt, Touche Ross, Honeywell and L’Nard Associates. Mr. Jackson serves on the Board of The Vista School, as well as several venture-backed companies.
Follow Martin Jackson:
About Select Medical: Select Medical treats approximately 30,000 patients in a typical day.
Diane Marcou
Consulting CFO of Satellite Bio
Ms. Marcou has provided financial and strategic advisory services to a number of venture-backed technology companies, including ByAllAccounts, Inc., Fluidnet Corporation, Radianse and T2 Biosystems. Prior to working as an independent financial consultant, she was Chief Financial Officer and Vice President of Finance and Administration for Incentive Systems (dba Centive), a privately held venture-funded software company, and Chief Financial Officer at Workgroup Technologies, a publicly traded software company with domestic and international operations. Ms. Marcou earned a B.S. in Business Administration from Boston College, and her CPA from PricewaterhouseCoopers, formerly Coopers & Lybrand.
Follow Diane Marcou:
About Boston MicroFluidics, Cytrellis Biosystems, Incentive Systems, Satellite Bio, Workgroup Technology: Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.
Jeff Fisher
Executive Vice President and CFO of Covenant Physician Partners
Follow Jeff Fisher:
About Covenant Physician Partners: Covenant Physician Partners is a privately-held owner and operator of ambulatory surgery centers.
Joseph Talamo
Senior Vice President and Chief Financial Officer of HiberCell
Joseph Talamo is the Senior Vice President and Chief Financial Officer at HiberCell.
Follow Joseph Talamo:
About HiberCell: HiberCell is a biotechnology company developing treatments to prevent cancer relapse and metastasis.
Peter C. Wulff
Chief Financial Officer of JenaValve Technology
Peter C. Wulff is the chief financial officer of [JenaValve Technology](https://www.crunchbase.com/organization/jenavalve-technology#/entity), a provider of TAVI systems for transapical and transfemoral implantation. Prior to that, he was the chief financial officer and chief operating officer of Pure Bioscience. Before joining Pure Bioscience, Wulff served as the chief financial officer, vice president, and treasurer at Alphatec Spine. Previously, he was the executive vice president and chief financial officer of Artes Medical. He has also been employed at CryoCor, Ligand Pharmaceuticals, and IMED Corporation. Wulff holds a bachelor’s degree in economics and master’s degree in finance from Indiana University Bloomington. He resides in San Diego, California, United States.
Follow Peter C. Wulff:
About JenaValve Technology: JenaValve Technology develops transcatheter aortic valve implantation (TAVI) systems for transapical and transfemoral implantation.
Aaron Freidin
Chief Financial Officer of Grail
Aaron Freidin is Chief Financial Officer at Grail.
Follow Aaron Freidin:
About Grail: Grail develops a pan-cancer screening test designed to detect cancers at an early stage.
Jason Linscott
CFO of Texas Health Presbyterian Hospital Rockwall
Follow Jason Linscott:
About Texas Health Presbyterian Hospital Rockwall, Texas Health Presbyterian Hospital Rockwall: Texas Health Presbyterian Hospital Rockwall is a hospital & health care firm offering acute care services.
Bruce Margetich
Chief Financial Officer of FamilyWize
Bruce has over 25 years’ experience and expertise in operations, corporate financial planning and capital markets through a broad-based financial background that includes public accounting and financial management for both publicly held and privately owned companies. Bruce has been a member of the Board of Directors for many companies and assumed operating roles, led companies in developing comprehensive and cohesive growth plans, and other strategic business initiatives. Bruce and his wife, Sharon, live in Malvern, PA and have three daughters.
Follow Bruce Margetich:
About FamilyWize: FamilyWize has been dedicated to helping improve the health and well-being of individuals, families.
Michael Banks
CFO of Kineta
Michael Banks serves as the Chief Financial Officer of Kineta.
Follow Michael Banks:
About Kineta: Kineta aims at developing edge therapeutics in autoimmune disease, viral disease, and chronic pain areas.
Peter Aranow
Chief Financial Officer of Respiratory Motion
Mr. Aranow is the Chairman of Boynton Angels, a Worcester investor group that invests in start-up companies. Peter Aranow has spent 30 years in finance. For 17 years he was in the investment banking department of Bear Stearns & Co., where he worked on debt and equity financings, mergers and acquisitions, and was the investment banker responsible for Bear Stearns’ initial public offering. For the following 13 years he served as chief financial officer for a number of public and privately-owned companies, including an Internet advertising company and the New York City Off-Track Betting Corporation. Mr. Aranow holds an BA from Harvard College and an MBA from Harvard Business School.
Follow Peter Aranow:
About Harvard Business School Community Action Partners, Off Track Betting New York, Respiratory Motion: Respiratory Motion ExSpiron is FDA and CE Mark cleared and non-invasively measures minute ventilation, the fundamental unit of breathing.
Eric Davis
Chief Financial Officer of Seno Medical Instruments
Eric Davis is Chief Financial Officer of Seno Medical Instruments, Inc. Eric brings more than 26 years of financial and operational leadership with extensive domestic and international experience. He’s co-led several M&A efforts resulting in aggregate purchase prices over $500M and secured over $200M in investment capital. He’s a critical strategic thinker who also has the ability to define and implement at a tactical level. Eric was most recently the Chief Financial Officer of CeloNova BioSciences, Inc., a privately held medical device company who sold their Interventional Radiology/Oncology business to Boston Scientific at the end of 2015. Prior to CeloNova, Eric was the Chief Financial and Operating Officer at Genesis Networks Enterprises, LLC where he led the finance and accounting operations of a $1 billion network integrations and supply chain management company. Prior to Genesis, Eric spent time operating as senior finance and operations management in the Oil and Gas, Banking and Brokerage and Aero-Defense industries. Eric holds an MBA from Baylor University and BSBA in Management from the University of Tulsa. He’s also been inducted into the prestigious Beta Gamma Sigma honor society as a lifetime member and awarded Chartered Fellow (CMgr FCMI) by the Chartered Management Institute and Fellow Chartered Management Accountant (FCMA) and Chartered Global Management Accountant (CGMA) by the Chartered Institute of Management Accountants. He also holds certifications from Villanova University as a Certified Six Sigma Black Belt (CSSBB) and Certified Lean Six Sigma Sensei (CLSSS).
Follow Eric Davis:
About Seno Medical Instruments: Seno Medical is commercialization efforts in opto-acoustic imaging of breast cancer.
Douglas Larson
Group Chief Financial Officer of Beyond Air
Douglas Larson is the Group Chief Financial Officer at Beyond Air.
Follow Douglas Larson:
About Beyond Air: Beyond Air is a biotechnology company focused on the development of drugs for the treatment of lung infections.
Kimi Iguchi
CFO of SAGE Therapeutics
Kimi Iguchi joined SAGE Therapeutics in March 2013 as Chief Financial Officer with more than 15 years of progressive experience managing finance, accounting, operations and human resources in emerging life science companies. Prior to joining SAGE, Ms. Iguchi has led the organizational development of strategic business plans, portfolio management, deal structure, fund raising, financial planning, and operations infrastructure design and growth. She has held positions at Warp Drive Bio, LLC, Santhera Pharmaceuticals, Cyberkinetics, Millennium Pharmaceuticals and Biogen, Inc. She began her career at PricewaterhouseCoopers LLP, Boston. Ms. Iguchi holds a B.A. in chemistry from Drew University, received her MBA from Northeastern University, and earned her CPA in Massachusetts.
Follow Kimi Iguchi:
About SAGE Therapeutics: SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.
Mary Reumuth
Chief Financial Officer of Kala Pharmaceuticals
Ms. Reumuth joined Kala in February of 2014 as Senior Director, Finance and Corporate Controller. She brings with her nearly 20 years of diversified finance and accounting experience. Ms. Reumuth was formerly Corporate Controller for Enobia Pharma (acquired by Alexion Pharmaceuticals). Prior to her tenure at Enobia, she spent several years at Genzyme Corporation in Cambridge, MA through the acquisition of ILEX Oncology in San Antonio, Texas. Ms. Reumuth began her career as an auditor with the San Antonio office of Ernst & Young LLP. Ms. Reumuth earned her business degree from Texas A&M University – Corpus Christi and is a Certified Public Accountant.
Follow Mary Reumuth:
About Kala Pharmaceuticals: Kala Pharmaceuticals develops novel treatments for diseases that affect mucosal tissues.
Randy Sieve
Chief Financial Officer of HydraFacial
Randy Sieve has served as chief financial officer for HydraFacial since March 2018. Prior to joining the company, Randy held the CFO position for Columbus Manufacturing. He has over 30 years of experience, serving in positions with companies such as Central Garden & Pet Company, Diageo PLC, The Blommer Chocolate Company, Nabisco Brands, and QVC Network.
Follow Randy Sieve:
About HydraFacial: HydraFacial is an FDA registered manufacturer of advanced aesthetic technologies and products.
Scott Anderson
Co-Founder & CEO/CFO of Halfort Medical Solutions
Scott Anderson is the Chief Executive Officer and Chairman of Northeast Wireless Networks, LLC. Prior to joining Northeast Wireless Networks, LLC and since 1997-98, Scott Anderson has been a principal in Cedar Grove Partners, LLC, an investment partnership, and in Cedar Grove Investments, LLC, a private seed capital fund. In his role at Cedar Grove, Scott Anderson has had substantial investment and Board experience with early/later stage companies in a variety of industries, including wireless and teleco, petroleum engineering, retail coffee and defense contracting. From 1986 until 1997, Scott Anderson was employed by McCaw Cellular Communications and AT&T Wireless Services, Inc., where he served in various legal and M&A-related positions, last serving as Senior Vice President of the Acquisitions and Development group. In that role, he was oversaw all McCaw’s M&A, focusing on rural and smaller metropolitan markets. Before his employment at McCaw, Scott Anderson was engaged in private law practice in Seattle.Mr. Anderson is currently Chairman of the Board at Root Wireless and a director of Kratos Defense and Security, Inc., (NASDAQ: KTOS), mInfo Inc., Globys, Inc., Digital Scirocco, Inc. and Anvil Corporation.
Follow Scott Anderson:
About Cedar Grove Investments, Halfort Medical Solutions, Northeast Wireless Networks: Halfort Medical Solutions, healthcare staffing company, focuses on meeting urgent and short-term staffing needs of its clients.
Daniel Florin
Interim Chief Executive Officer, Senior Vice President and Chief Financial Officer of Zimmer Biomet
Dan Florin was appointed Interim Chief Executive Officer and a member of the Board of Directors on July 11, 2017. In addition, he serves as Senior Vice President and Chief Financial Officer, a position he has held since June 2015. Mr. Florin served as Senior Vice President and Chief Financial Officer of Biomet from June 2007 to June 2015.Prior to joining Biomet, Mr. Florin served as Vice President and Corporate Controller of Boston Scientific Corporation from 2001 until 2007. Before being appointed Corporate Controller in 2001, Mr. Florin served in financial leadership positions within Boston Scientific Corporation and its various business units. Prior to joining Boston Scientific Corporation, Mr. Florin worked for C.R. Bard from October 1990 through June 1995, and was employed by Deloitte from September 1986 to October 1990. Mr. Florin holds a Bachelor’s degree in Business Administration with a concentration in Accounting from the University of Notre Dame and an Executive MBA from Boston University.
Follow Daniel Florin:
About Zimmer Biomet: Zimmer Biomet designs, develops, manufactures, and markets orthopedic reconstructive and spinal products.
Steve Maiocco
Chief Financial Officer of Schooner Capital
Steve has been Schooner’s Chief Financial Officer since 1996. A Managing Director, Steve divides his time between Schooner’s internal financial and administrative matters and Schooner’s investment portfolio, including serving as a board member of Millstone Medical Outsourcing and Iron Rail Group. Prior to joining Schooner, Steve spent approximately fourteen years in public accounting at Tonneson & Company CPAs P.C. where he worked with his clients on a wide range of accounting, financial and tax matters. Steve has an undergraduate degree from Cornell University and a Master’s of Science in Taxation degree from Bentley University. He is also licensed as a Certified Public Accountant in the Commonwealth of Massachusetts.
Follow Steve Maiocco:
About Schooner Capital: Schooner Capital is a Boston-based private investment firm engaged in venture capital, growth equity, and public securities.
Jeff Poulton
Chief Financial Officer of Alnylam Pharmaceuticals
Follow Jeff Poulton:
About Alnylam Pharmaceuticals: Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Vikram Bakhru
Chief Operating Officer & Chief Financial Officer of ConsejoSano
Dr. Vik Bakhru is a physician, senior healthcare executive and entrepreneur who has served in numerous executive roles in healthcare and business. He is currently the Chief Operating Officer at ConsejoSano, a leading venture-backed health technology platform that enables payers and providers to simplify care, increase engagement and lower costs. Previously, Dr. Bakhru was Chief Operating Officer of First Opinion, Inc. Before First Opinion, Inc., Dr. Bakhru served as Chief Medical Officer for Abercrombie & Kent Global Health, a Fortress Investment Group portfolio company that facilitates high quality, affordable medical travel. In addition, Dr. Bakhru worked as a Director at New York Presbyterian Hospital/The University Hospital of Columbia and Cornell in New York City where he managed an annual spend base of approximately $600 million for the purchase of all clinical goods and services. Prior to his role at NYP, Dr. Bakhru worked with the Foundation for International Medical Relief of Children (FIMRC), a non-profit he founded while completing his medical degree at The George Washington University School of Medicine & Health Sciences in Washington, DC. FIMRC (www.fimrc.org) is a 501(c)3 non-profit organization dedicated to providing health care access in underserved areas of the developing world through a network of health centers in nine countries across 12 project sites. FIMRC now boasts a team of over 3,000 full-time staff and volunteers. Dr. Bakhru serves on the Board of Directors for several organizations including the Nanubhai Education Foundation, Aspire Global Health and FIMRC. Dr. Bakhru’s professional affiliations include membership in the American College of Surgeons, the American Medical Association and the American Telemedicine Association. He has been practicing medicine since 2007 and is currently a licensed physician in 17 states (AZ, CA, DC, FL, GA, IL, MA, MD, MI, NC, NY, OH, PA, UT, VA, WA, WI). He is clinically active as a private practitioner and as an on-call physician at UCSF Medical Center and Main Line Health. Dr. Bakhru earned a Bachelor of Arts in Economics and a Bachelor of Science in Biology from The George Washington University as part of the Seven-Year Integrated Medical Program. After his undergraduate and medical education in Washington, DC, Dr. Bakhru did residency training in general surgery in Philadelphia and subsequently earned a Master of Business Administration degree in Health Care Management from The Wharton School of the University of Pennsylvania. Recognitions include the American Medical Association Foundation Excellence in Leadership Award, The George Washington University Award, the Kaiser Family Foundation Grant, the Becker’s Hospital Review: Rising Stars in Healthcare Award, and most recently was named to the Wharton Forty Under Forty for 2017. Dr. Bakhru gives over a dozen keynote speeches and participates in numerous panel discussions per year. His topics include clinical medicine, digital health, entrepreneurship, global health, innovation, leadership, Medicaid/Medicare, patient engagement, product development & technology, social determinants of health, robotics, and user experience. He has presented at the Indian Institute of Management, HIMSS Precision Medicine Summit, Stanford Medicine X, HIMSS Pop Health Forum, 7th Digital Health London, HIMSS Digital & Personal Health Forum, UCLA Anderson Healthcare Conference, Entrepreneur’s Summit, MIT Sloan Healthcare & Bioinnovation Conference, Ayusmat Healthcare Leadership Summit and The Wharton School, University of Pennsylvania (Philadelphia, Pennsylvania).
Follow Vikram Bakhru:
About ConsejoSano, First Opinion Medical Services, Mir Ventures: Multicultural engagement and navigation solutions
Peter Collum
Chief Financial Officer and Chief Business Officer of Pharnext
More than 17 years’ experience in healthcare investment banking focused on M&A, financing and business development transactions. Previously partner at MTS Health Partners for public and private life sciences companies both in the US and abroad, and worked in the healthcare investment banking group at Bank of America. Started at Roche as an engineer.
Follow Peter Collum:
About Pharnext: Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.
Ryan Buchholtz
Interim CFO of Laicos, Inc.
Follow Ryan Buchholtz:
About Laicos, Inc.: A Tampa Based Startup Studio turning ideas into products into companies
Mike McDonald
CFO of ThermiAesthetics
Follow Mike McDonald:
About ThermiAesthetics: ThermiAesthetics is a developer and manufacturer of thermistor-regulated energy systems for plastic surgery and dermatology applications.
Brian M. Campbell
CFO of HemoShear Therapeutics
Campbell has been an entrepreneur and an economic consultant throughout his 40-year business career. He began in 1968 with an aviation consulting firm in New York and was promoted to Vice President of their Washington office in 1973. In 1977, Campbell co-founded Midway Airlines, Inc., the first new start-up carrier after airline deregulation, where he served as CFO and participated in the raising of venture capital to fund the airline’s launch. Campbell returned to the aviation consulting business in 1983 and is currently chairman of The Campbell-Hill Aviation Group in Alexandria, VA. Campbell has assisted numerous start-up companies with business plan preparation, financial forecasting, detailed market analyses, and strategic planning studies. Campbell currently serves as vice chairman and acting CFO of Dynamic Literacy, LLC, advisor to Targeson, LLC, a University of Virginia (UVa)-based biotechnology company, advisor and investor in BioMotion Analytics, LLC, is a member of the advisory board of UVa’s Heart and Vascular Center, and serves on the UVa Patent Foundation Advisory Panel. Campbell earned a Bachelor of Commerce from McGill University, an MBA from the University of Western Ontario, and a PhD in Business Administration from Columbia University.
Follow Brian M. Campbell:
About Dynamic Literacy, HemoShear Therapeutics: HemoShear Therapeutics develops new treatments for patients with rare metabolic disorders.
Adam Derbyshire
Chief Financial Officer of Salix Pharmaceuticals
Adam Derbyshire is the CFO at Salix Pharmaceuticals.
Follow Adam Derbyshire:
About Salix Pharmaceuticals: Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Stephen M. Robb
Executive Vice President – Chief Financial Officer of The Clorox Company
Stephen M. “Steve” Robb was named executive vice president – chief financial officer in 2014 after three years as senior vice president – chief financial officer. In this role, he is the senior executive responsible for Clorox’s financial activities, including accounting, reporting, internal Controls, treasury, tax and investor relations. Prior to being named CFO, Robb served as vice president – Global Finance, with responsibility for the company’s day-to-day finance operations, including tax, treasury, accounting, and financial planning and analysis. Other positions with Clorox have included vice president – Financial Planning and Analysis and vice president – Finance and Accounting, Household Segment. Robb joined Clorox in 1989 and has held assignments in several business units as well as a variety of corporate staff positions. Since 2004, Robb has overseen The Clorox Company’s cost savings efforts, a key strategic commitment for the company under its 2020 Strategy. Under his stewardship, cost savings efforts have produced an average of $100 million in savings annually. A native of Sunnyvale, Calif., Robb holds a bachelor’s degree in finance with a minor in economics from San Jose State University.
Follow Stephen M. Robb:
About The Clorox Company: The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products.
Ted Jeong
Chief Financial Officer of Clene Nanomedicine
Ted Jeong is the Chief Financial Officer of Clene Nanomedicine. He has a master’s degree in Finance at The Johns Hopkins University.
Follow Ted Jeong:
About Clene Nanomedicine: Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.
David Cordo
CFO of Metamark Genetics
Mr. Cordo began his career in the life sciences industry in 1990. He held senior management positions in finance at Biogen Idec during his seven-year tenure where he put in place the financial infrastructure for the worldwide commercial launch of Avonex. For seven years, he was the Treasurer of Millennium Pharmaceuticals. At Millennium, he led finance teams in the raising of an $800 million follow-on equity offering and a $400 million convertible debt offering. He also led finance teams for three acquisitions. Dave has been interim chief financial officer for several venture capital backed life science companies, including Dicerna Pharmaceuticals, Epizyme, Inc., Link Medicine Corporation, TransForm Pharmaceuticals, Avila Therapeutics and Alinea Pharmaceuticals, and consulting on strategic financial issues for public and private life science companies. He is a Certified Public Accountant and holds an M.B.A. degree from Nichols College and a B.S.B.A. degree from Stonehill College. He is an active member of the Executive Committee of the Wake Forest University Parents’ Council and consults for several charitable organizations.
Follow David Cordo:
About Metamark Genetics, Novartis, Potenza Therapeutics, Semma Therapeutics: Metamark Genetics develops prognostic and predictive diagnostic tests that enable personalized treatment planning for cancer patients.
John Maley
Chief Financial Officer of AliveCor
Follow John Maley:
About AliveCor: AliveCor is a FDA-cleared mobile heart solution that helps save lives, save money, and brings healthcare into the 21st century.
Jay Green
Chief Financial Officer of Optum
Jay Green is the Chief Financial Officer at MedHOK.
Follow Jay Green:
About MedHOK, Optum: OptumInsight provides analytics, technology, and consulting services to improve the performance of health systems.
Jay Green
Chief Financial Officer of Optum
Jay Green is the Chief Financial Officer at MedHOK.
Follow Jay Green:
About MedHOK, Optum: OptumInsight provides analytics, technology, and consulting services to improve the performance of health systems.
Laurie Silver
Chief Financial Officer of BrainScope Company
Laurie Silver has over 20 years’ experience with a financial, accounting, strategic planning and operations background. Prior to BrainScope, she served as Director of Mergers and Acquisitions for the Services group at Symantec, where she led the integration of the Services organizations upon the $13 billion merger of Symantec and Veritas, which was the largest software company merger in history. Prior to Symantec, Ms. Silver was the Vice President of Finance and Administration of TrueCareers, a subsidiary of Sallie Mae; Manager of Financial Planning and Analysis across all business units of ABC/Disney; and a Senior Auditor at Ernst & Young LLP in New York. Ms. Silver graduated from the Stephen M. Ross School of Business at the University of Michigan and earned a CPA license from the State of New York. She has been with BrainScope since 2009.
Follow Laurie Silver:
About BrainScope Company: Brainscope is a medical neurotechnology company that improves brain health.
Nathan Weems
Chief Financial Officer of VitalConnect
Nathan has accrued over 13 years of operational excellence in management roles spanning finance, business development, and marketing, most recently serving as Sr. Director of Finance at Natera, a public Bay Area biotech company. Earlier experience includes tenure at a top Wall Street investment bank and Big-4 accounting firm. Nathan brings expertise in accounting, due diligence, market research, fund raising and investor relations. He holds a BA from the University of Southern California and an MBA from Wharton. When his HP 12C is not within reach, you can usually find Nathan on two wheels or two skis exploring the outdoors with his family.
Follow Nathan Weems:
About VitalConnect: VitalConnect is a wearable biosensor technology for wireless hospital and remote patient monitoring.
David Murray
Chief Financial Officer of Alcon
Follow David Murray:
About Alcon: Alcon specializes in developing and manufacturing innovative medicines and devices to serve the full life cycle of eye care needs.
Matthew Stack
Chief Financial Officer of Koning
Matt Stack is a founder of XLP Capital, the founding manager of the Lambda Prime Investment Incubator Fund, and the Chief Investment Officer of XLP’s technology activist fund, Devonshire Capital Fund I. He is an experienced early and seed stage investor in high tech hardware and analytics companies with over $200M in completed deals, and serves as a technology advisor to a variety of institutions and family offices overseeing and directing over $500M. Over the past decade, Matt has acquired and developed a collection of minority interests in companies across North America ranging from small university spin outs to mid-sized industrial technology companies. Matt serves as an advisor to a number of privately held companies, where he manages and supervises technology and high performance computing investments. Matt has served as the Director of Computational Science at Mars Corporation and as a Partner at 3LP – a Boston-based elite Intellectual Property advisory firm. Matt’s prior experiences include managing acquisitions for a $120M corporate-led technology buyout fund in Palo Alto, as well as spending 6 years at The Boston Consulting Group in the Boston and New York offices, where he worked on projects in the Health Care, IT, Retail, Industrial Goods, and Strategy practice areas. He frequently helped corporate clients with topics including corporate growth strategy, merger and acquisitions, and post-merger integration. Before BCG, Matt co-founded and invested in a health care software startup, a small electronics company, an advanced composites design firm, and a semiconductor distribution company that traded high performance semiconductor chips between Shenzhen, Tokyo, and Tecate. Matt holds a B.S.E. in electrical engineering from Princeton University. He is a benefactor and sponsor of the TEDx conference series, and has sponsored research at the Santa Fe Institute in New Mexico, the Strategy Institute in New York, MIT’s Broad Institute, the Highlands Forum, the University of Oxford, and the Department of Defense. He is an accomplished computer hacker and cryptanalyst, and has written and advised on state-run network cyber-warfare policy, and agility-based strategic combat. Matt was recognized in 2009 by Hackaday as one of the top 10 most influential hardware hackers, and has been featured in Wired Magazine and the Wall Street Journal for his hobby electronics projects. He is the author of 11 neuroscience patents covering devices, analytical methods, and algorithms for detecting concussion and improving cognitive performance. In his spare time, he has been an Olympic hopeful in javelin, a competitive speedskater, a motorcycle collector, and is currently a professional windsurfer.
Follow Matthew Stack:
About Koning, XLP Capital: 3D Breast CT, Breast Cancer detection, Breast cancer diagnostics
Will Rousmaniere
Chief Financial Officer of Analogic
Will joined Analogic in 2012 as finance director for the company’s Ultrasound Business. In 2015 he was named senior director, financial planning and analysis. Prior to joining Analogic, Will was director of finance, precision motion and technologies at GSI Group (now Novanta), and held multiple financial leadership roles at Varian Semiconductor Equipment Associates (now a division of Applied Materials) as well as financial and operational roles at a number of technology start-ups. He earned an MBA in finance and accounting from New York University, Stern School of Business, and a BA in Economics from Cornell University and was a Certified Public Accountant.
Follow Will Rousmaniere:
About Analogic: Analogic is a technology company that develops computed tomography, ultrasound, digital mammography, and magnetic resonance imaging systems.
Claudia Stein Martin
Chief Financial Officer of Vyne
Claudia Stein-Martin is Chief Financial Officer of Vyne. Claudia oversees all company accounting practices, financial reporting, financial strategy, and budgetary planning. Claudia has over 15 years of experience in the public accounting, financial services and manufacturing industries. Claudia’s broad experience includes positions with Arthur Andersen LLP, a controller at Auto Nation’s Financial Services Division (a fortune 500 company), and she also served as CFO of Sundance Products, Inc. Claudia graduated Summa Cum Laude earning a Bachelor of Accounting and a Bachelor of Finance degree from Florida Atlantic University.
Follow Claudia Stein Martin:
About Vyne: Vyne serves the health services ecosystem wherever providers, patients, and payers interact.
Tim Kelly
Chief Financial Officer of Praxis Precision Medicines
Tim Kelly is the Chief Financial Officer at Praxis Precision Medicines.
Follow Tim Kelly:
About Praxis Precision Medicines: Praxis Precision Medicines offers drug development services.
Jonathan Tu
CFO & Co-Founder of Fluxergy
Jonathan Tu is the Chief Financial Officer and Co-Founder at Fluxergy.
Follow Jonathan Tu:
About Fluxergy: Fluxergy is a biotechnology company that offers point-of-care testing, PCR, and medical diagnostics.
Shaffiq Rahim
Chief Financial Officer of Helinet Aviation Services
Shaffiq Rahim is the President at Hi-Tech Engineering.
Follow Shaffiq Rahim:
About Creek Bridge Capital, Helinet Aviation Services, Hi-Tech Engineering: Helinet Aviation Services is a diversified helicopter transportation provider located in Van Nuys, California.
Paul Burton
CFO of 4D Healthware
Paul Burton, JD, MBA – Biography • Paul Burton has been the CEO of Akan Biosciences since December 2018. Akan is a biotech startup based in Maryland developing regenerative medicinal therapeutics. In September, the Company expects to start a Phase 2A trial for a cellular therapy for osteoarthritis of knee. • Through Burton Advisory, Inc. Paul provides strategic and financial advice to healthcare companies. Clients include a mix of early stage biotech as well as some digital healthcare companies such as Cancer IQ, Care Advisors and 4D Healthware. • In addition, Paul is currently an Entrepreneur In Residence at Northwestern University supporting students and faculty with healthcare oriented commercialization projects. • He was the CEO of ResQ Pharma, Inc. from July 2015 through December 2018. • He co-founded Vivacelle Bio, Inc. and was employed as its CFO and a member of its Board of Directors (BOD) from 2012 through 2015. • He is a Member of MATTER, a Chicago based healthcare incubator and the Bunker Labs, an Incubator started in Chicago for U.S. military veterans. • Paul has over 20 years of experience in corporate finance and strategic advisory including as an investment banker starting with Salomon Brothers in NYC and later in London (now Citigroup Corporate & Investment Bank) and as a VP at GE Capital in Stamford, CT. • He worked as the CFO for a unionized specialty construction contracting company for 3 years in Illinois. • Paul is published in several peer reviewed scientific research journals including the European Journal of Pharmacology. • Served as a U.S. Regular Army Commissioned Officer (Infantry) upon completion of the University of Illinois at Chicago’s Army ROTC program in 1990 (Distinguished Military Graduate). • He is former Member of the University of Illinois Urbana-Champaign (UIUC) MBA Advisory Board and UIUC College of Law Recent Alumni Advisory Board. • Paul served as a Board Trustee for Evanston History Center formerly known as the Evanston Historical Society from June 2014 to June 2020. • He serves as Finance Chair for Hemenway United Methodist Church (Evanston). • Paul has enjoyed living in Evanston with wife and son since 2007.
Follow Paul Burton:
About 4D Healthware: 4D Healthware is patient engagement software that makes personalized medicine possible through connected data.
Joel Richardson
Chief Financial Officer of MobileHelp
Mr. Richardson has more than 27 years of experience leading financial management and corporate operations both in and out of the technology sector. His responsibilities and duties have included SEC and financial reporting, equity and debt capital raisings, financial planning and analysis, investor relations, and human resources for companies in rapidly changing markets. Prior to joining MobileHelp, Mr. Richardson was responsible for developing and maintaining the accounting infrastructure and financial systems of AlertSite, a leading web performance and transaction monitoring company.
Follow Joel Richardson:
About MobileHelp: MobileHelp™ is a Boca Raton, Florida, healthcare technology company.
John Slump
Chief Financial Officer of Surgical Innovation Associates
Follow John Slump:
About Surgical Innovation Associates: Surgical Innovation Associates is a developer of implantable polymeric surgical devices for plastic, reconstructive, and general surgery.
Janel Fillinger
Chief Financial Officer of Clinical Innovations
Mrs. Fillinger joined CI in September 2013 and has over 17 years of experience in financial management. She joined CI from C.R. Bard, where she held a variety of finance and management positions, most recently serving as Vice President and Controller of Bard Access Systems Division. Before her tenure with C.R. Bard, she was an auditor at Ernst & Young.
Follow Janel Fillinger:
About Clinical Innovations: Develops, manufactures and markets state-of-the-art medical devices
Raj Matthew
Chief Financial Officer of Doctor Direct
Raised $1.2BB in public/private placements and negotiated over $1.3BB in transactions at Asante Technologies, PeopleWeb Communications and Vivato Networks. As CFO for Asante Technologies exceeded analyst expectations on turnaround plan while tripling analyst coverage. As CFO, led IPO process at PeopleWeb Communications, positioned company to analysts and investment bankers. Part of senior finance team that led the spin-off of PacTel Corporation, (Vodafone Airtouch) in the 4th largest IPO in US history, concurrent with a billion dollar debt offering. As VP Finance & Controller, led M&A team that managed a total of 10 mergers/acquisitions (4 public, 6 private companies) in 26 months at Avant!-Synopsys, while company grew to 42 offices in 16 countries, over 1000 employees, annual bookings in excess of $400 MM. Arranged $700MM in syndicated financing and refinanced $250MM in convertible bonds at Conner-Seagate during explosive growth, (reached $1.2BB in revenue in 13 months).
Follow Raj Matthew:
About Doctor Direct: Doctor Direct is an exciting company in the rapidly expanding Healthcare – remote patient monitoring space.
David Pool
Chief Financial Officer of Ocunexus Therapeutics
Mr. Pool joined CoDa Therapeutics as Chief Financial Officer in July 2008. He has over 20 years investment banking and venture capital experience including privatization transactions, leasing, securitizations, venture capital raising and initial public offerings. Mr. Pool has raised over $50M for early stage Biotech companies. Mr. Pool’s responsibilities include all financial and accounting functions as well as driving CoDa’s fund raising process and business development activities. Prior to CoDa, Mr. Pool was Protemix Corporation’s Chief Operating and Financial Officer for 5 years. Mr. Pool holds a Bachelor of Commerce in accounting and business administration from the University of Canterbury and is a member of the Institute of Chartered Accountants of New Zealand.
Follow David Pool:
About Inflammx Therapeutics, Ocunexus Therapeutics: Ocunexus Therapeutics is a biopharmaceutical company that develops therapeutics for unmet clinical needs in ophthalmology.
Tom O’Neil
Chief Financial Officer of Protagonist Therapeutics
Tom O’Neil is the chief financial officer of [Arcadia Biosciences](https://www.crunchbase.com/organization/arcadia-biosciences#/entity), an agricultural technology company focused on developing products that benefit the environment and human health. Prior to that, he held the same position at Sorbent Therapeutics. O’Neil has also served as the vice president of finance and marketing at ChemGenex Pharmaceuticals and as a team member at HX Diagnostics. O’Neil holds a bachelor’s degree in international relations from Pomona College and master’s degree in business administration from the University of California, Los Angeles. He lives in San Francisco, California, United States.
Follow Tom O’Neil:
About Nodality, Protagonist Therapeutics: Protagonist Therapeutics develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies.
Genevieve Barnard
CFO & Co-Founder of MDaaS Global
Genevieve Barnard is the CFO and Co- founder of MDaaS. She used to be the associate director of associate director at Kletjian Foundation. Genevieve earned her MBA at Massachusetts Institute of Technology – Sloan School of Management.
Follow Genevieve Barnard:
About MDaaS Global: MDaaS Global operates tech-enabled diagnostic centers in clinically-underserved communities.
Brian Lenz
Vice President, Chief Financial Officer of ADMA Biologics
Mr. Lenz joined ADMA as VP, Chief Financial Officer in May 2012. Mr. Lenz was previously at CorMedix Inc., a developmental-stage pharmaceutical and medical device company, where he held the position of Chief Financial Officer from February 2010 and Chief Operating Officer and Chief Financial Officer from January 2012. Prior to joining CorMedix, Mr. Lenz served as Chief Financial Officer of Arno Therapeutics, Inc. from July 2008 to February 2010, Chief Financial Officer of VioQuest Pharmaceuticals, Inc. from April 2004 to June 2008, Controller of Chiral Quest, Inc., a subsidiary of VioQuest Pharmaceuticals, from October 2003 to March 2004, Controller of Smiths Detection from July 2000 to October 2003, and senior auditor at KPMG, LLP from October 1998 to July 2000. Mr. Lenz received a B.S. from Rider University, an M.B.A. from Saint Joseph’s University and is a licensed Certified Public Accountant.
Follow Brian Lenz:
About ADMA Biologics: ADMA Biologics develops plasma-based biologics for the treatment and prevention of certain infectious diseases.
David McClung
Vice President of Finance & Accounting(Chief Financial Officer) of BioCardia
David McClung has served as our Vice President of Finance since 2016 and has been with the company since September 2013. Mr. McClung has more than 20 years of finance and accounting experience in publicly and privately financed organizations, including startup enterprises, middle-market businesses and large public companies. For the last ten years he has held leadership roles in emerging businesses, primarily life science ventures, most recently as the Controller for Sonitus Medical Inc. and NextWave Pharmaceuticals, Inc. He spent his early career in public accounting, beginning with KPMG LLP, after which he gained broad financial and operational experience directing the North American audit group for The Clorox Company and serving as Director of Internal Audit for Matson Navigation, Inc. Mr. McClung earned a Bachelor of Arts degree in Accounting from Georgia State University, graduating with honors. He is an actively licensed CPA and member of the AICPA and the California Society of CPAs.
Follow David McClung:
About BioCardia: BioCardia is a clinical-stage regenerative medicine company.
Mark Schonau
Chief Financial Officer of Matrix Medical Network
Mark Schonau is an experienced Chief Financial Officer with 25 plus years of experience providing financial and operational leadership to public and venture backed corporations. Mr. Schonau has provided financial leadership to software companies in the Healthcare Information Technology, Transportation and B2B Commerce. Before moving into the private sector he spent eight years working for Ernst & Young as an auditor. Mr. Schonau has a Bachelor of Science Degree in Accounting from Arizona State University, is licensed as a CPA in the State of Arizona and holds a Certificate in Global Leadership from the Thunderbird School of International Management.
Follow Mark Schonau:
About Matrix Medical Network: Matrix Medical Network is a Health Care company.